Venus to commence ground magnetics survey at Pincher Well


Published 29-MAY-2017 14:27 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Venus Metals Corporation (ASX: VMC) has released details relating to second phase IP surveying conducted at its Pincher Well zinc prospect located in Western Australia. Lying 600 kilometres north-north-east of Perth the prospect forms part of the company’s Youanmi gold and base metal project.

Tenements E57/986 and E57/1019 hosting the trend are situated 15 kilometres south-west of the Youanmi gold mine and processing plant. Consequently, should VMC be able to progress the project there will be significant benefits from having access to nearby infrastructure.

Of course this is an early stage play and investors should seek professional financial advice if considering this stock for their portfolio.

The Pincher Dome Volcanogenic Massive Sulphide (VMS) trend covers more than 5 kilometres of strike and hosts a number of known zinc and copper prospects including the Linda and Franca Gossans, PW17 zinc discovery and a substantial body of zinc mineralisation at North Dome.

Recent reconnaissance drilling over the earlier IP anomaly confirmed the presence of significant thick and shallow ‘up dip’ extension of the known North Dome zinc-copper mineralisation.

Significant intercepts included 10 metres grading 7.3% zinc from 52 metres and 10 metres grading 5.1% zinc from 68 metres.

With these robust thicknesses and strong grades, the second phase of IP survey has been extremely insightful. The chargeability recorded in recent IP survey by comparison is stronger than the previous results and effectively extends the anomaly 400 metres to the south.

The modelled anomaly remains open and untested further to the south, potentially extending the target envelope of 1 kilometre strike and 250 metres in width.

A ground magnetic survey is commencing immediately to refine the targets with management extremely upbeat about what may materialise from these anomalies.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free